To the Editor: Chronic granulomatous disease (CGD) is an inherited disease that aff ects superoxide production by phagocytic cells and inhibits their ability to kill bacteria and fungi. CGD is most commonly X-linked recessive but can also be autosomal recessive and usually presents in childhood, leading to recurrent infection and granuloma formation. Th e granulomatous obstruction of hollow viscera is well described. Gastrointestinal involvement is common and varied (1 -3) . Hepatic involvement typically includes abscess, drug injury, and nodular regenerative hyperplasia. Gastrointestinal tract luminal involvement is typically an infl ammatory bowel disease -like syndrome, including fi stula formation and obstructive symptoms. Esophageal involvement is rare and the most-described cases have been in children. Th is report of esophageal involvement in an adult with CGD highlights the natural history of esophageal disease over 20 years.
Th e patient is a 48-year-old man who was diagnosed with CGD in 1988 at the age of 27 years, aft er his brother was diagnosed with CGD at autopsy. He has had intermittent dysphagia throughout his life. His initial presentation of dysphagia was at the age of 9 years, when he had esophageal strictures, which were treated with dilations. During his initial visit aft er the diagnosis of CGD, he was given antibiotics and prednisone for 2 months and his dysphagia symptoms were resolved for several months.
Since his initial diagnosis, he has been followed up at the National Institutes of Health on multiple medication regimens, including antibiotics and steroids. Th roughout the years, the patient has had intermittent dysphagia that has been worse with solids than liquids. He reports that his dysphagia worsens when he is not taking steroids. In the 1990s, he had meat impactions requiring endoscopy several times a year. In 1989, 1992, and 2006, the patient had esophograms ( Figure 1 ), which showed " multiple sacculations. " Th e radiology report states that when the patient drank water aft er drinking barium it " looked like a toilet washing out the barium " and descended stepwise out of the esophagus. Th e patient has had multiple endoscopies, which are useful for comparison with the barium studies ( Figure 2 ). Th e endoscopies have consistently shown diverticula, which contain undigested food and strictures throughout the esophagus. Endoscopic biopsy of the strictures showed reactive changes without granulomata.
Presently, his diffi culty in swallowing solids is managed by sitting upright while eating. His dysphagia has worsened since becoming edentulous. In addition, he has had diffi culty with dentures. Recent refl ux and heartburn with occasional chest pain are relieved with over-thecounter antacids. He also complains of halitosis and a bad taste in his mouth that can last for several days at a time.
Th e descriptions of esophageal involvement in CGD consist of case reports with varying presentations, typically involving children. Esophageal involvement in CGD includes motility and structural abnormalities. However, there are no previous studies or case reports with longterm follow-up. Th erefore, this 20-year follow-up of an adult patient with severe symptomatic CGD-related esophageal involvement is of potential value.
Two adults with CGD and dysphagia have been described (4, 5) . Golioto and O ' Connor described a 27-year-old man with progressive dysphagia, a normal barium swallow, endoscopy, and pathology but manometry showing diff use esophageal spasm. A chest computerized tomography scan also showed periesophageal adenopathy and thickening of the esophageal wall. Th e authors suggested that the motility disorder might have been secondary to mediastional adenopathy. Renner et al. dysphagia. Th eir case is similar to ours in that he had strictures and pseudodiverticulosis. However, their patient was successfully treated with repeated dilations without using steroids.
Hiller et al. (6) and Renner et al. (5) , respectively, described 5-and 14-yearold girls with esophageal strictures. Both patients had progressive dysphagia that responded to steroids, but symptoms recurred with withdrawal of steroids. Th e pathology in both was normal or nonspecifi c. Markowitz et al. (7) presented the case of an 11-year-old boy with chest pain and vomiting. Esophogram showed a dilated esophagus with areas of narrowing and the " esophageal body was atonic. " Antibiotics, dilation, and atropine were unsuccessful. Th e patient eventually received a gastric tube for feeding. Chin et al. (8) described a 10-year-old boy with progressive dysphagia, whose barium swallow showed esophageal narrowing and thickened gastric mucosa. Antibiotics caused no improvement, nor did steroids followed by dilation.
Higher-dose steroids resulted in symptom improvement and in the improvement in his barium swallow. Ruiz-Contreras et al. (9) described a 14-year-old boy with progressive dysphagia and weight loss, whose barium swallow showed a rigid, narrow esophagus with normal mucosa, and whose pathology was non-specifi c. He received antibiotics for 3 weeks and became asymptomatic for 2.5 months. Recurrence led to antibiotics and steroids. On barium examination, aft er the combination of antibiotics and steroids, there was an almost complete resolution of the stricture.
Our patient is unique because his dysphagia has been followed up since his diagnosis of CGD in 1988. Th roughout follow-up, his symptoms have fl uctuated, but the anatomy of his esophagus has not changed signifi cantly. Although progression might have been expected, both his symptoms and anatomy have remained relatively stable. Th e patient has not had meat impaction for several years, raising the question of whether the strictures have enlarged over time to allow easy passage of meat. Some of the earlier cases have had only functional dysmotility, whereas our patient has strictures, diverticula, and presumed dysmotility. It is interesting to note that despite long-term signifi cant infl ammation of the esophagus, there is no evidence of pre-malignant or malignant lesions in this patient.
As in the previous case reports, anatomical pathology has not given any clues as to why esophageal dysfunction occurs. It is suspected that granulomatous infl ammation causes strictures, although this has not been shown. Alternatively, functional dysmotility may exist before anatomical changes. Because the patient in this case had anatomical changes upon presentation, the full evolution of his illness has been missed. As the management of CGD has improved and patients are living longer, non-infectious complications are becoming increasingly relevant. Esophageal involvement in CGD should be suspected in the appropriate clinical setting, worked up, and aggressively managed. To the Editor: Th e synthetic analog (13-cis -retinoic acid) of vitamin A, isotretinoin (Accutane, Amnesteem, Clarovis, Decutan, Isotane, Sortret) is indicated for the treatment of patients with severe recalcitrant nodular acne who have failed conventional therapy (1) . Reddy et al. (2) conducted the only systematic review of the association between isotretinoin and infl ammatory bowel disease (IBD) in 2006. In all, 85 cases were reported to MedWatch, the FDA ' s Safety Information and Adverse Event Reporting Program system, between 1997 and 2002 in which the symptoms of colitis were attributed to isotretinoin. Using the Naranjo Adverse Drug Reaction Probability Scale, the authors scored 5 % of the cases as " highly probable, " 68 % as " probable, " and 27 % in the " possible " range. In the years since publication of this article, hundreds of lawsuits have been fi led against drugmakers alleging a causal relationship between isotretretinoin and IBD.
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We question whether IBD may in fact be part of the disease of severe acne and raise the possibility that the incidence of IBD in patients taking isotretinoin may at least partially represent an epiphenomenon. Many autoimmune disorders are syndromal in that the presence of one aspect of the disorder signals the predisposition to other associated infl ammatory conditions. Th e most severe form of acne, acne conglobata, is associated with seronegative arthritis, polyarthralgia, and pyoderma gangrenosum (PG), all also systemic manifestations of IBD (3, 4) . PG was reported by Rosner et al. in 3 of 10 patients with acne conglobata or hidradenitis suppurativa and seronegative polyarthritis (5) . In a comprehensive study of 86 patients presenting PG, 78 % of patients had at least one other infl ammatory disease including IBD and acne conglobabta (6) . PAPA (pyogenic arthitis, PG, and acne) syndrome is an autosomal dominant disorder that presents with cystic acne, PG, and pyogenic sterile arthritis (3) . Th is triad of diseases has been mapped to chromosome 15q between loci D15S1023 and D15S979 (7) . Knitzer and Needleman (8) identifi ed 59 cases from medical literature of infl ammatory acne in conjunction with polyarthritis or polyarthralgia and classifi ed these syndromes into three groups, one of which occurs as a response to isotretinoin.
Interestingly, recent research suggests that retinoic acid may at least theoretically prevent autoimmunity and reduce anti-infl ammatory eff ects by promoting anti-infl ammatory regulatory T-cell differentiation and inhibiting the induction of proinfl ammatory T helper 17 cells (9) . As medical professionals we owe it to our patients to rigorously analyze the association between isotretinoin and IBD. Further research is needed to determine the true incidence of IBD in patients with severe acne, and whether using isotretinoin may act as a trigger for IBD in a certain subset of patients. It is incumbent that we, both in dermatology and gastroenterology, engage in rigorous case -control trials so that adequate informed consent is provided to patients regarding the true risks of taking isotretinoin.
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